Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$170.78 - $208.42 $102,468 - $125,051
-600 Reduced 28.56%
1,501 $276,000
Q4 2023

Jan 18, 2024

BUY
$114.17 - $185.35 $239,871 - $389,420
2,101 New
2,101 $378,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Trevian Wealth Management LLC Portfolio

Follow Trevian Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trevian Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trevian Wealth Management LLC with notifications on news.